YS Biopharmas new HBV vaccine enters Phase I trials
| YSDelisted Stock | 0.48 0.03 5.88% |
Slightly above 62% of YS Biopharma's investor base is looking to short. The analysis of current outlook of investing in YS Biopharma Co, suggests that many traders are alarmed regarding YS Biopharma's prospects. YS Biopharma's investing sentiment can be driven by a variety of factors including economic data, YS Biopharma's earnings reports, geopolitical events, and overall market trends.
YS Biopharma |
YS Biopharmas new HBV vaccine enters Phase I trials
Read at investing.com
 |
YS Biopharma Fundamental Analysis
We analyze YS Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
YS Biopharma is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
YS Biopharma Co, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with YS Biopharma stock to make a market-neutral strategy. Peer analysis of YS Biopharma could also be used in its relative valuation, which is a method of valuing YS Biopharma by comparing valuation metrics with similar companies.
Peers
YS Biopharma Related Equities
| CDIO | Cardio Diagnostics | 9.26 | ||||
| ZURA | Zura Bio | 0.72 | ||||
| QNRX | Quoin Pharmaceuticals | 0.14 | ||||
| ZVSA | ZyVersa Therapeutics | 0.00 | ||||
| CNSP | Cns Pharmaceuticals | 0.91 | ||||
| VRAX | Virax Biolabs | 1.63 | ||||
| BDRX | Biodexa Pharmaceticals | 2.90 | ||||
| SONN | Sonnet Biotherapeutics | 5.71 | ||||
| REVB | Revelation Biosciences | 5.76 | ||||
| ALLR | Allarity Therapeutics | 6.42 | ||||
| IMMX | Immix Biopharma | 13.78 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |